Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Gonzalo Blanco, Anna Vardi, Anna Puiggros, Andrea Gómez-Llonín, Manuel Muro, María Rodríguez-Rivera, Evangelia Stalika, Eugenia Abella, Eva Gimeno, Manuela López-Sánchez, Alicia Senín, Xavier Calvo, Pau Abrisqueta, Francesc Bosch, Ana Ferrer, Kostas Stamatopoulos & Blanca Espinet. (2018) Restricted T cell receptor repertoire in CLL-like monoclonal B cell lymphocytosis and early stage CLL. OncoImmunology 7:6.
Read now
Read now
Parviz Kokhaei, Farhad Jadidi-Niaragh, Abdolreza Sotoodeh Jahromi, Anders Osterborg, Håkan Mellstedt & Mohammad Hojjat-Farsangi. (2016) Ibrutinib-A double-edge sword in cancer and autoimmune disorders. Journal of Drug Targeting 24:5, pages 373-385.
Read now
Read now
Articles from other publishers (14)
Shrinidhi Nathany, Anurag Mehta, Himanshi Diwan, Dushyant Kumar, Sakshi Mattoo, Surender Dhanda, ManojK Panigrahi & Manoj Kumar. (2022) Somatic hypermutation in CLL: From bench to bedside. Journal of Current Oncology 5:1, pages 52.
Crossref
Crossref
Gema Perez-Chacon & Juan M. Zapata. (2021) The Traf2DNxBCL2-tg Mouse Model of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Recapitulates the Biased IGHV Gene Usage, Stereotypy, and Antigen-Specific HCDR3 Selection of Its Human Counterpart. Frontiers in Immunology 12.
Crossref
Crossref
Naeem Khan & Thomas L. Rothstein. (2021) The Alternate Pathway for BCR Signaling Induced by IL-4 Requires Lyn Tyrosine Kinase. Journal of Molecular Biology 433:1, pages 166667.
Crossref
Crossref
Sunil K. Noothi, Mary K. McKenna, Sara S. Alhakeem, James P. Collard, J. T. Greene, Natarajan Muthusamy, Vivek M. Rangnekar & Subbarao Bondada. 2021. Tumor Suppressor Par-4. Tumor Suppressor Par-4
133
148
.
Monica Colombo, Davide Bagnara, Daniele Reverberi, Serena Matis, Martina Cardillo, Rosanna Massara, Luca Mastracci, Jean Louis Ravetti, Luca Agnelli, Antonino Neri, Michela Mazzocco, Margherita Squillario, Andrea Nicola Mazzarello, Giovanna Cutrona, Andreas Agathangelidis, Kostas Stamatopoulos, Manlio Ferrarini & Franco Fais. (2020) Tracing CLL-biased stereotyped immunoglobulin gene rearrangements in normal B cell subsets using a high-throughput immunogenetic approach. Molecular Medicine 26:1.
Crossref
Crossref
Ali Sakhdari & L. Jeffrey Medeiros. (2019) Update on Lymphoma classification: The 2016 revised World Health Organization Classification of Hematopoietic and Lymphoid Neoplasms. ADVANCES IN CELL AND GENE THERAPY 2:3.
Crossref
Crossref
Eric D. Hsi. 2018. Hematopathology. Hematopathology
397
413.e2
.
Prabhjot KaurPrabhjot Kaur. 2018. Chronic Lymphocytic Leukemia. Chronic Lymphocytic Leukemia
61
89
.
Ana E. Rodríguez-Vicente, Vasilis Bikos, María Hernández-Sánchez, Jitka Malcikova, Jesús-María Hernández-Rivas & Sarka Pospisilova. (2017) Next-generation sequencing in chronic lymphocytic leukemia: recent findings and new horizons. Oncotarget 8:41, pages 71234-71248.
Crossref
Crossref
Mohosin Sarkar, Yun Liu, Junpeng Qi, Haiyong Peng, Jumpei Morimoto, Christoph Rader, Nicholas Chiorazzi & Thomas Kodadek. (2016) Targeting Stereotyped B Cell Receptors from Chronic Lymphocytic Leukemia Patients with Synthetic Antigen Surrogates. Journal of Biological Chemistry 291:14, pages 7558-7570.
Crossref
Crossref
Lydia Scarfò & Paolo Ghia. (2016) What does it mean I have a monoclonal B-cell lymphocytosis?: Recent insights and new challenges. Seminars in Oncology 43:2, pages 201-208.
Crossref
Crossref
Sameer A. Parikh & Tait D. Shanafelt. (2016) Prognostic factors and risk stratification in chronic lymphocytic leukemia. Seminars in Oncology 43:2, pages 233-240.
Crossref
Crossref
Elisa ten Hacken & Jan A. Burger. (2016) Microenvironment interactions and B-cell receptor signaling in Chronic Lymphocytic Leukemia: Implications for disease pathogenesis and treatment. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1863:3, pages 401-413.
Crossref
Crossref
Panagiotis BaliakasAndreas AgathangelidisAnastasia HadzidimitriouLesley-Ann SuttonEva MingaAthina TsanousaLydia ScarfòZadie DavisXiao-Jie YanTait ShanafeltKarla PlevovaYorick SandbergFie Juhl VojdemanMyriam BoudjograTatiana TzenouMaria ChatzouliCharles C. ChuSilvio VeroneseAnne GardinerLarry MansouriKarin E. SmedbyLone Bredo PedersenDenis MorenoKirsten Van LomVéronique GiudicelliHana Skuhrova FrancovaFlorence Nguyen-KhacPanagiotis PanagiotidisGunnar JuliussonLefteris AngelisAchilles AnagnostopoulosMarie-Paule LefrancMonica FaccoLivio TrentinMark CatherwoodMarco MontilloChristian H. GeislerAnton W. LangerakSarka PospisilovaNicholas ChiorazziDavid OscierDiane F. Jelinek, Nikos Darzentas, Chrysoula BelessiFrederic DaviPaolo GhiaRichard RosenquistKostas Stamatopoulos. (2015) Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations. Blood 125:5, pages 856-859.
Crossref
Crossref